Related Experiment Videos
Aspirin, a silent risk factor in urology
J P Zhu1, M B Davidsen, H H Meyhoff
1Department of Surgery A, Hillerød Hospital, Denmark.
Scandinavian Journal of Urology and Nephrology
|December 1, 1995
Summary
Aspirin use may increase bleeding risks during urologic procedures like prostatectomy and biopsy. Stopping aspirin a week prior and using specific treatments can manage these aspirin-induced hemorrhagic complications.
Area of Science:
- Urology
- Pharmacology
- Hemostasis
Background:
- Aspirin is widely used for pain, inflammation, fever, and cardiovascular prophylaxis.
- Aspirin use is associated with increased operative hemorrhagic complications, particularly relevant in urology.
- Understanding aspirin's pharmacological effects on hemostasis is crucial for managing surgical risks.
Purpose of the Study:
- To review the normal hemostatic mechanism and aspirin's effect on hemostasis.
- To examine literature on aspirin-induced hemorrhagic complications in urologic procedures.
- To describe strategies for managing bleeding complications in patients on aspirin.
Main Methods:
- Literature review of aspirin's pharmacological effects on hemostasis.
- Systematic review of reported hemorrhagic complications in urologic surgery.
- Analysis of management strategies for bleeding complications.
Main Results:
- Aspirin increases bleeding and transfusion needs after prostatectomy, though large trials are lacking.
- Hemorrhagic complications are reported following prostate biopsy and extracorporeal shock wave lithotripsy.
- Cessation of aspirin one week prior to procedures is suggested.
Conclusions:
- Aspirin poses a bleeding risk in urologic procedures.
- Pre-operative aspirin cessation and specific interventions can manage bleeding.
- Further placebo-controlled trials are needed to confirm risks and optimal management.